| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.32 | 2e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-06 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-05 |